On Monday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the CALYPSO Phase 3 trial designed to evaluate the efficacy and safety of eneboparatide in adults with chronic hypoparathyroidi[...]
Read more
Articles written by Vandana Singh
Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline
On Tuesday, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) agreed to acquire Chimerix Inc (NASDAQ:CMRX) for $8.55 per share in cash, representing a total consideration of approximately $935 million. Both comp[...]
Read more
CVS Health Q4 Earnings: Prescription Volume Up 5.9%, Upbeat FY25 Outlook and More
On Wednesday, CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total revenues increased 4.2%, driven by growth in the Health Care Be[...]
Read more
World Health Organization Responds to Trump’s Order, Reminds Decades of Successful Health Achievements
President Donald Trump signed an executive order on January 20, 2025, initiating the United States’ withdrawal from the World Health Organization (WHO). The move marks a continuance of Trump’s first-t[...]
Read more
Getty Images Weighs Major Merger with Shutterstock
Getty Images Holdings Inc. (NYSE:GETY) is reportedly exploring a potential merger with rival Shutterstock Inc. (NYSE:SSTK). The deliberations, disclosed by unnamed sources, reveal that Getty is consid[...]
Read more
Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks ‘Swift End’ And ‘To Protect Its Interests’
As expected by many, Eli Lilly And Co (NYSE:LLY) filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and FarmaKeio Custom Compounding against the FDA. T[...]
Read more
Cigna And Humana Revive Early Merger Talks After Year-Long Pause
In a significant development in the health insurance industry, Cigna Group (NYSE:CI) has reinitiated discussions to merge with Humana Inc. (NYSE:HUM), potentially creating a giant in the sector. Talks[...]
Read more